New study: Fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Dana-Farber's Toni Choueiri, MD, highlights the research.
Dana Farber cancer Stewart is a founding member of c. C C. 19. Covid and cancer database which is the largest cohort of cancer patient with covid 19. And in this most recent study we evaluated breakthrough COVID-19 infection in patients with cancer. This is the first study to evaluate the clinical characteristics but also the clinical outcomes Of these cancer patients who experienced breakthrough infection following COVID-19 vaccination. We defined vaccinated uh not had booster because booster at that time of day to capture was not considered part of the vaccination. You know without being vaccination, patients with cancer at our higher risk for 30 day mortality. Hospitalization. ICU stay mechanical ventilation. Same thing we found here that vaccinated the patient overall, you know with Covid remained at really high risk. If you develop breakthrough covid 19 following full vaccination your remain susceptible to severe outcomes, especially this patient with him malignancies. So you need to continue, you know the boosters. So boosters vaccinating close context of patient masking social distancing. I think it should continue especially in patients with cancer and especially pharmacologic cancers
